Durable Response With Sequential Tyrosine Kinase Inhibitor Treatment in a Patient With ROS1 Fusion-Positive Pancreatic Adenocarcinoma: A Case Report.
Theresa ReutterJana FassunkeMichael PüskenJan-Phillip WeberElke BinotAnna EisertRieke FischerLucia NogovaRichard RiedelDiana SchauflerHeather ScharpenseelMatthias SchefflerHolger SchulzDirk-Thomas WaldschmidtThomas ZanderSabine Merkelbach-BrusePeter SchirmacherReinhard ButtnerJuergen WolfSebastian MichelsPublished in: JCO precision oncology (2023)